Skip to main content
Clinical Trials/NCT04982016
NCT04982016UnknownNot Applicable

Effects of Preoperative Fluid Therapy on Microcirculatory Reactivity in Patients With MIDCAB After General Anesthesia

Beijing Anzhen Hospital0 sites126 target enrollmentStarted: September 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
126
Primary Endpoint
Change in DesStO2 is assessed

Study Overview

Brief Summary

Through preoperative fluid therapy, to investigate whether it can alleviate the microcirculation dysfunction after induction of anesthesia, and reduce the incidence of perioperative fluid therapy-related complications, thereby accelerating rehabilitation.

Detailed Description

Patients undergoing minimally invasive coronary artery bypass graft surgery were randomly divided into crystal group, colloid group and control group. The preoperative fluid reactivity was evaluated according to the passive leg lifting test (PLR). When stroke volume increased (△SV)>16%, the patients in the crystal (carbonate Ringer solution) and the colloid group (hydroxyethyl starch solution) were treated with volume therapy, while the control group was not treated with PLR test and volume therapy. Vascular occlusion test was used to observe the effect of anesthesia induction on tissue oxygen saturation recovery slope (RecStO2) after volume therapy, Goal-directed fluid therapy was used during operation, and the postoperative microcirculation function and the incidence of related complications were observed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years old
  • Plan to undergo elective minimally invasive coronary artery bypass grafting (left anterior descending branch);
  • Sign informed consent

Exclusion Criteria

  • Left ventricular ejection fraction <40%
  • Renal insufficiency (serum creatinine>177umol/L)
  • Liver insufficiency (AST, ALT>3 times)
  • Peripheral vascular disease
  • Carotid artery stenosis (>60%) VOT test contraindications (arm deformity, burns, arteriovenous shunt)
  • Use glucocorticoids, vasoactive drugs, inotropic drugs or intra-aortic balloon counterpulsation (IABP)
  • Allergic to colloidal fluids

Outcomes

Primary Outcomes

Change in DesStO2 is assessed

Time Frame: The microcirculation function is measured at 4 time points: patients entered the operating room; 5 minutes after volume therapy; 30 minutes after anesthesia induction; and at the end of the operation

DesStO2(%/min):The downhill slope of StO2 reflects the oxygen consumption rate

Change in tM is assessed

Time Frame: The microcirculation function is measured at 4 time points: patients entered the operating room; 5 minutes after volume therapy; 30 minutes after anesthesia induction; and at the end of the operation

The time for minimum value of StO2 to recover to maximum value of StO2

Secondary Outcomes

  • Change in heart rate is assessed(4 time points: patients entered the operating room; 5 minutes after volume therapy; 30 minutes after anesthesia induction; and at the end of the operation)
  • Change in HS is assessed(4 time points: patients entered the operating room; 5 minutes after volume therapy; 30 minutes after anesthesia induction; and at the end of the operation)
  • Duration of stay in the intensive care unit(up to 60 days)
  • Change in SDC-1 is assessed(4 time points: patients entered the operating room; 5 minutes after volume therapy; 30 minutes after anesthesia induction; and at the end of the operation)
  • Change in mean arterial pressure is assessed(4 time points: patients entered the operating room; 5 minutes after volume therapy; 30 minutes after anesthesia induction; and at the end of the operation)
  • Length of hospital stay(up to 60 days)

Investigators

Sponsor
Beijing Anzhen Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Boqun Cui

Deputy chief physician

Beijing Anzhen Hospital

Similar Trials